Data on the mucolytic mechanism of action of Lynovex will be presented at NACFC 2018.

NovaBiotics today announces that data on the mechanism of action of the active agent of its Lynovex product candidates for cystic fibrosis (CF) has been selected for presentation at the North American Cystic Fibrosis Conference (NACFC), Denver, CO, October 18-21, 2018. NACFC is organised by the Cystic Fibrosis Foundation and is a key annual event that brings together clinicians, scientists, caregivers, industry and all CF community stakeholders.